insights_auto
Why is TMCI down 3,90%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,44 $
arrow_downward
-3,90%(-0,18) 1D
4,44 $
0,00% (0,00)
bedtimeAfter hours
Closed: 30 қыр., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,62 $
High
4,62 $
Low
4,43 $
Mkt. cap
288,75 млн
Avg. vol.
251,51 м.
Volume
157,59 м.
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,41
Shares outstanding
65,04 млн
No. of employees
450
Open
4,62 $
High
4,62 $
Low
4,43 $
Mkt. cap
288,75 млн
Avg. vol.
251,51 м.
Volume
157,59 м.
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,41
Shares outstanding
65,04 млн
No. of employees
450
News stories
From web sources and news partners
MarketBeat
·
13 сағат бұрын
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Consensus Target Price of $5.17 According to Brokerages
https://www.dars.gov.et/
·
2 ай бұрын
Treace Medical Concepts Inc. (TMCI) Q1 2026 Earnings: EPS Surprises to the Upside Despite Wider Loss - Pre-Earnings Setup
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc